Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Management
Kodenbushi
Investors
Overview
Regulation A Offering
Regulation A Offering
News / Events
Press Releases
Email Alerts
Company Information
Profile
Management Team
Scientific Advisory Board
Presentations
IR Contacts
FAQ
Video
Financial Information
Quarterly Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Email Alerts
Presentations
Tear Sheet
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Jun 29, 2016 • 9:32 AM EDT
Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome
Jun 23, 2016 • 5:02 AM EDT
Endonovo Therapeutics Awarded Preliminary Injunction Against Kodiak Capital et al
Jun 15, 2016 • 9:07 AM EDT
Endonovo Therapeutics Provides Update on Variable Convertible Notes
May 5, 2016 • 2:45 PM EDT
Endonovo Therapeutics to Present at the 2016 Marcum Microcap Conference in New York
Apr 13, 2016 • 8:34 AM EDT
Endonovo Therapeutics to Present at the SeeThruEquity 5th Annual Microcap Investor Conference in New York
Mar 30, 2016 • 3:12 PM EDT
Endonovo Therapeutics Receives USPTO Notice of Allowance for Patent Covering Production of Biomolecules From Adult Stem Cells
Mar 14, 2016 • 3:09 PM EDT
Endonovo Therapeutics Provides Corporate Update and 2016 Outlook
Feb 11, 2016 • 7:30 AM EST
Endonovo Therapeutics Retains Holland & Knight to File for Orphan Drug Designation
<< Previous
1
2
Show All